personal-finance Are Your Retirement Plans Resilient to Crises? Many Aren't. Here's How to Assess Them , and Administrator 2025 June 18
personal-finance Pharma giant Eli Lilly advances, leaving Novo Nordisk in retreat , and Administrator 2025 June 17
technology Investment prospects in handling the growing cohort of senior citizens , and Administrator 2025 June 14
technology Government Leader Reeves to Showcase £86 Billion Commitment Toward Science and Technology Projects in Forthcoming Financial Review , and Administrator 2025 June 11
personal-finance More than thirteen percent of employees work in the healthcare field. , and Administrator 2025 June 7
real-estate Entrepreneurs should skip the selling tactics on the moon and instead get straight to the point, according to Pauline Boucon Duval, DG and Business Angel. , and Administrator 2025 June 6
Investing Could Novo Nordisk stand as the leading pharmaceutical stock by 2030? , and Administrator 2025 May 27
real-estate Euler's Constant (e) Elucidated: Its Role in Finance Unveiled , and Administrator 2025 May 15
Investing TG Therapeutics' Shares Drop Post Q1 Earnings, Unsurprising Given the Assorted Obstacles Encountered , and Administrator 2025 May 12
personal-finance Reassessing the Advantages and Disadvantages of Re timing Marijuana Legalization , and Administrator 2025 May 12
Business Amidst price drops, Novo Nordisk's stock still offers a substantial 60% return. , and Administrator 2025 May 9
Business Negotiating Employee Benefit Costs in Our Websites: Insights and Strategies , and Administrator 2025 May 4
Business Reducing Costs of Employee Benefits Through Web-Based Negotiations , and Administrator 2025 May 2
Business Pharmaceutical company GSK has a strong standing to absorb new tariffs in the US pharmaceutical sector , and Administrator 2025 May 2
technology "MedIQ, a Pakistani health technology company, bagged a $6 million investment" , and Administrator 2025 May 1
Business Pharmaceutical Company GSK Reports Robust Performance, Affirms Confidence in Maintaining Position Amid Potential Pharmaceutical Taxes , and Administrator 2025 April 30
